Delivery Order SPE2DR25D2217-SPE2DR26FC7DB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,415.62 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count supply). This is a firm fixed-price, non-set-aside competitive award issued on December 3, 2025, with completion scheduled for December 4, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,128.12 delivery order on December 3, 2025, for 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in cardiac care. This is a firm fixed-price, non-set-aside contract with a completion date of December 4, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,701.65 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count) with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply...
- The Defense Logistics Agency awarded a $1,549.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Corlanor 5 mg tablets (60-count). This is a non-set-aside contract with an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.12 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a cardiac medication used to treat heart failure. This firm fixed-price delivery order, issued December 5, 2025, represents a non-set-aside, competitively awarded contract with a completion deadline of December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,911.92 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 19, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the open...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,630.57 for Corlanor 5 mg tablets (60-count units) on November 6, 2025, with an ultimate completion date of November 7, 2025. This competitive award utilized firm fixed-price pricing with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $9,479.97 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,589.66 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg on December 2, 2025, with completion expected by December 3, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement under a child contract arrangement. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $4,484.78. This firm fixed-price delivery order is scheduled for completion by September 19, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D2217Indefinite Delivery Contract
- SPE2DR25D2217-SPE2DR26FC7DBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,110.41 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Corlanor 5 mg tablets (60-unit packages). This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates significant capability in fulfilling diverse pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/7/25 |